DK1458391T3 - Fremgangsmåde til at behandle bakterielle infektioner ved anvendelse af gemifloxacin eller et salt deraf og et beta-lactamantibiotikum - Google Patents
Fremgangsmåde til at behandle bakterielle infektioner ved anvendelse af gemifloxacin eller et salt deraf og et beta-lactamantibiotikumInfo
- Publication number
- DK1458391T3 DK1458391T3 DK02795444T DK02795444T DK1458391T3 DK 1458391 T3 DK1458391 T3 DK 1458391T3 DK 02795444 T DK02795444 T DK 02795444T DK 02795444 T DK02795444 T DK 02795444T DK 1458391 T3 DK1458391 T3 DK 1458391T3
- Authority
- DK
- Denmark
- Prior art keywords
- gemifloxacin
- beta
- salt
- bacterial infections
- lactam antibiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33449501P | 2001-11-30 | 2001-11-30 | |
| PCT/KR2002/002248 WO2003045390A1 (en) | 2001-11-30 | 2002-11-29 | A METHOD OF TREATING BACTERIAL INFECTIONS USING GEMIFLOXACIN OR A SALT THEREOF AND A β -LACTAM ANTIBIOTIC |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1458391T3 true DK1458391T3 (da) | 2008-01-07 |
Family
ID=23307473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02795444T DK1458391T3 (da) | 2001-11-30 | 2002-11-29 | Fremgangsmåde til at behandle bakterielle infektioner ved anvendelse af gemifloxacin eller et salt deraf og et beta-lactamantibiotikum |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7169792B2 (no) |
| EP (1) | EP1458391B1 (no) |
| AT (1) | ATE372119T1 (no) |
| AU (1) | AU2002360218A1 (no) |
| CA (1) | CA2468036C (no) |
| CY (1) | CY1107038T1 (no) |
| DE (1) | DE60222298T2 (no) |
| DK (1) | DK1458391T3 (no) |
| ES (1) | ES2292844T3 (no) |
| MX (1) | MXPA04005179A (no) |
| NO (1) | NO333196B1 (no) |
| PT (1) | PT1458391E (no) |
| WO (1) | WO2003045390A1 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20080289A1 (it) * | 2008-02-22 | 2009-08-23 | S I F I Societa Industria Farmaceutica Italia | Composizioni di gemifloxacina con elevata efficacia su patologie oculari |
| EP2143422A1 (en) * | 2008-07-11 | 2010-01-13 | S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. | Ophthalmic compositions containing gemifloxacin for the treatment of ocular infections |
| EP2536408A1 (en) * | 2010-02-16 | 2012-12-26 | Wockhardt Research Centre | Efflux pump inhibitors |
| ES2568647T3 (es) * | 2010-02-25 | 2016-05-03 | Santen Pharmaceutical Co., Ltd | Gotas oftálmicas para tratar infección ocular que contienen levofloxacino, sal del mismo o solvato del mismo, método de tratamiento de infección ocular, levofloxacino, sal del mismo o solvato del mismo, y su uso |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3711343A1 (de) * | 1987-04-03 | 1988-10-20 | Bayer Ag | Cephalosporinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| MA24500A1 (fr) * | 1997-03-21 | 1998-10-01 | Lg Life Sciences Ltd | Derive du sel d'acide carboxylique de naphthyridine . |
| US6576224B1 (en) * | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
-
2002
- 2002-11-29 EP EP02795444A patent/EP1458391B1/en not_active Expired - Lifetime
- 2002-11-29 WO PCT/KR2002/002248 patent/WO2003045390A1/en active IP Right Grant
- 2002-11-29 AU AU2002360218A patent/AU2002360218A1/en not_active Abandoned
- 2002-11-29 DE DE60222298T patent/DE60222298T2/de not_active Expired - Lifetime
- 2002-11-29 CA CA002468036A patent/CA2468036C/en not_active Expired - Lifetime
- 2002-11-29 PT PT02795444T patent/PT1458391E/pt unknown
- 2002-11-29 MX MXPA04005179A patent/MXPA04005179A/es active IP Right Grant
- 2002-11-29 ES ES02795444T patent/ES2292844T3/es not_active Expired - Lifetime
- 2002-11-29 US US10/496,809 patent/US7169792B2/en not_active Expired - Lifetime
- 2002-11-29 AT AT02795444T patent/ATE372119T1/de active
- 2002-11-29 DK DK02795444T patent/DK1458391T3/da active
-
2004
- 2004-06-28 NO NO20042711A patent/NO333196B1/no not_active IP Right Cessation
-
2007
- 2007-11-28 CY CY20071101521T patent/CY1107038T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003045390A1 (en) | 2003-06-05 |
| ATE372119T1 (de) | 2007-09-15 |
| US7169792B2 (en) | 2007-01-30 |
| NO333196B1 (no) | 2013-04-02 |
| US20050148571A1 (en) | 2005-07-07 |
| MXPA04005179A (es) | 2004-08-11 |
| DE60222298T2 (de) | 2008-01-03 |
| NO20042711L (no) | 2004-06-30 |
| EP1458391A4 (en) | 2005-05-11 |
| EP1458391A1 (en) | 2004-09-22 |
| CA2468036C (en) | 2008-01-22 |
| ES2292844T3 (es) | 2008-03-16 |
| PT1458391E (pt) | 2007-12-10 |
| AU2002360218A1 (en) | 2003-06-10 |
| DE60222298D1 (de) | 2007-10-18 |
| EP1458391B1 (en) | 2007-09-05 |
| CA2468036A1 (en) | 2003-06-05 |
| CY1107038T1 (el) | 2012-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY138285A (en) | Fab i inhibitors | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| NO20052362D0 (no) | Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner | |
| NO20025204D0 (no) | Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner | |
| SE0202598D0 (sv) | Alpha-7 Nicotinic receptor agonists and statins in combination | |
| DE602004012269D1 (de) | Quervernetzte glycopeptid-cephalosporin-antibiotika | |
| DK1037650T3 (da) | Præparater til behandling af Staphylococcus aureus-infektioner | |
| DE602004024393D1 (de) | Quervernetzte glycopeptid-cephalosporin-antibiotika | |
| DE60208404D1 (de) | Kreuzverquerte glycopeptid-cephalosporin-antibiotika | |
| DK1057828T3 (da) | Orale trovafloxacin-suspensioner | |
| DK1641436T3 (da) | Inhalerbar aztreonamlysinatformulering til behandling af og forebyggelse mod bakterielle lungeinfektioner | |
| IL162689A0 (en) | Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections | |
| DK1301207T3 (da) | Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin | |
| DE60131085D1 (de) | Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika | |
| CY1107038T1 (el) | Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης | |
| DK1458390T3 (da) | Fremgangsmåde til behandling af bakterielle infektioner ved anvendelse af gemifloxacin eller et salt deraf og et carbapenem antibakterielt middel | |
| DE60137459D1 (de) | Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen | |
| CL2004000139A1 (es) | Compuestos derivados de bencimidazol, inhibidores de girasa; composicion farmaceutica; utiles en el tratamiento, prevencion o disminucion de infecciones bacterianas. | |
| PL370662A1 (en) | Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections | |
| IT1304822B1 (it) | Composizione anticrittogamica particolarmente idonea per trattareinfezioni fungine e batteriche delle piante. |